Notification
Show More
Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel
Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel
Search
Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel
Follow US
Tag:
US52490G1022
Health
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Achieved 100% ORR and 83.3% CR rate at dose level 2 following…
GlobeNews Wire
14/06/2026
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
I have read and agree to the terms & conditions
Leave this field empty if you're human:
Welcome Back!
Sign in to your account
Username or Email Address
Password
Remember me
Lost your password?